Rapid Optimisation of Performance Enhancement and Skill (ROPES)

February 13, 2025 updated by: Celia Tan Ia Choo, Singapore General Hospital

The Effectiveness of Rapid Optimisation of Performance Enhancement and Skill (ROPES) As an Exercise Training Programme for Sedentary Health Care Staff

Despite innate knowledge of the benefits of regular physical activity, healthcare workers are just as physically inactive as the general population. Physical activity interventions delivered at the workplace seem perfect to improve the health of this large population.

The aim of the study is to deliver an efficacious, minimal time impost training program targeted at optimising health benefit while overcoming time-related barriers to initial uptake of regular exercise.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

To evaluate the effectiveness of a 4-week, easily accessible, time-optimised exercise program (ROPES - Rapid Optimisation of Performance Enhancement and Skill) for healthcare workers.

60 staff recruited from Singapore General Hospital (SGH) will be randomly assigned into 2 groups, CONTROL or ROPES group. The ratio to intervention and control group is at 1:1. The staff will be assigned to each group respectively.

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Singapore, Singapore
        • Recruiting
        • Singapore General Hospital
        • Contact:
        • Contact:
          • Celia Ia Choo Tan, PhD (Dept of Surgery)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age group: 21 - 70 years old
  • All participants must be free of musculoskeletal, surgical and/or neurological injury in the past 6 months.
  • Participants not engaged actively in regular exercise i.e. exercises less than once a week and at a duration less than 30 mins per session.
  • Healthy with stable management of any existing diabetes, cholesterol and/or hypertension.
  • They should have no issues with the Physical Activity Readiness Questionnaire (PAR-Q)

Exclusion Criteria:

  • Participants under the age of 21 or over the age of 70
  • Newly diagnosed diabetes/metabolic syndrome/high cholesterol or uncontrolled high BP >160 mmHg and under medical supervision.
  • Subjects with cardiovascular conditions and on beta-blockers.
  • Subjects who are pregnant or with recent (< 3 months) diagnosis of a medical condition, especially cardiac-related conditions.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control
30 participants will be randomised into the CONTROL group and will continue to perform their normal activities. They will only be required to keep a log of their exercise intensity for each week over the 4-week period and record them on an online diary. The exercise log/diary consists of type of exercise, e.g. resistance or aerobic and duration of exercise session.
Experimental: ROPES
The intervention is a 4-week training exercise program conducted by trained Physiotherapists.
ROPES is a training programme that involves resistance training, whole-body exercises and HIIT aerobic sessions with each session lasting no longer than 45 minutes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physical work capacity
Time Frame: From enrollment to the end of study at 8 weeks

A standard physical work capacity test based on the linear relationship between heart rate, power output and oxygen consumption will estimate the work capacity.

The higher the heart rate, the better the physical work capacity. Minimum value of heart rate is 155 bpm and maximum value is 199 bpm.

From enrollment to the end of study at 8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Muscular Strength
Time Frame: From enrollment to the end of study at 8 weeks
Handgrip strength will be measured using a hand-held dynamometer to determine functional strength.
From enrollment to the end of study at 8 weeks
BMI
Time Frame: From enrollment to the end of study at 8 weeks
Height and weight will be measured on a body fat analyser and will be combined to report the BMI in kg/m^2.
From enrollment to the end of study at 8 weeks
Body Fat
Time Frame: From enrollment to the end of study at 8 weeks
Body fat will be measured on a body composition analyser and will be reported in percentage %.
From enrollment to the end of study at 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 2, 2025

Primary Completion (Estimated)

June 1, 2025

Study Completion (Estimated)

August 1, 2025

Study Registration Dates

First Submitted

December 17, 2024

First Submitted That Met QC Criteria

December 22, 2024

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

February 13, 2025

Last Verified

December 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 2024-3861

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sedentary Lifestyle

Clinical Trials on ROPES Training Programme

Subscribe